1-6 of 6
Laura Gibson, PHD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Serum Mir-29a Is Up-Regulated In Acute Graft Versus Host Disease (aGVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (allo HSCT) and Activates Dendritic Cells (DCs)

Yvonne A Efebera, MD, Parvathi Ranganathan, Ph.D, Xueyan Yu, Ph.D, Jessica Hofstetter, BS, Sabrina L Garman, BS, Laura Gibson, PhD, William Petros, Michael Craig, MD, Cecelia Fernandez-Cymering, BS, Mehdi Hamadani, MD, Guido Marcucci, MD, Steven M. Devine, MD, Muller Fabbri, MD, Ramiro Garzon, MD
Journal: Blood
Blood (2013) 122 (21): 4471.
https://doi.org/10.1182/blood.V122.21.4471.4471
Published: 2013
Journal Articles

Immunomodulation of Both Donors and Recipients with Atorvastatin As a Strategy for the Prevention of Acute Graft-Versus-Host Disease (aGVHD): Results of Two Parallel Prospective Trials in Recipients of Matched Sibling Allogeneic Hematopoietic Cell Transplantation (alloHCT)

Mehdi Hamadani, MD, Michael Craig, MD, Scot Remick, MD, FACP, Laura Gibson, PhD, William Petros, Jame Abraham, MD, FACP, Aaron Cumpston, PharmD, Pamela Bunner, BS, Soumit Basu, MD, William Tse, MD, Carrie Hennelly, Sumithira Vasu, MBBS, Rebecca B Klisovic, MD, William Blum, MD, Samantha M. Jaglowski, MD, MPH, Don M. Benson, Jr., MD, PhD, Leslie A Andritsos, MD, Sam Penza, MD, Craig C. Hofmeister, MD, Susan Geyer, PhD, Steven M. Devine, MD, Yvonne A Efebera, M.D.
Journal: Blood
Blood (2012) 120 (21): 1942.
https://doi.org/10.1182/blood.V120.21.1942.1942
Published: 2012
Journal Articles

In Vivo T-Cell Depletion Does Not Improve Rates of Graft-Versus-Host Disease and Transplantation Outcomes In Patients Undergoing Peripheral Blood Hematopoietic Cell Transplant.

Abraham S Kanate, MD, Salman Osman, MD, Aaron Cumpston, PharmD, Gerry Hobbs, PhD, Sonia Leadmon, BS, Pamela Bunner, BS, Laura Gibson, PhD, William Tse, MD, Jame Abraham, MD, FACP, Scot Remick, MD, FACP, Michael Craig, MD, Sayed Mehdi Hamadani, MD
Journal: Blood
Blood (2010) 116 (21): 4536.
https://doi.org/10.1182/blood.V116.21.4536.4536
Published: 2010
Journal Articles

Response to Induction Chemotherapy with Novel Agents Does Not Predict Outcomes of Multiple Myeloma Patients Undergoing Autologous Hematopoietic Cell Transplantation

Salman Osman, MD, Abraham Sebastian Kanate, MD, Pamela Bunner, BS, Sonia Leadmon, BS, William Tse, Aaron Cumpston, PharmD, Laura Gibson, PhD, Scot Remick, MD, FACP, Jame Abraham, MD, FACP, Michael Craig, MD, Sayed Mehdi Hamadani, MD
Journal: Blood
Blood (2010) 116 (21): 1347.
https://doi.org/10.1182/blood.V116.21.1347.1347
Published: 2010
Journal Articles

Higher Infused CD34+ Cell Dose Improves Survival In Patients Undergoing In Vivo T-Cell Depleted, but Not T-Cell Replete Peripheral Blood Hematopoietic Cell Transplant

Abraham S Kanate, MD, Salman Osman, MD, Aaron Cumpston, PharmD, Gerry Hobbs, PhD, Sonia Leadmon, BS, Pamela Bunner, BS, Kathy Watkins, MT, Laura Gibson, PhD, William Tse, MD, Jame Abraham, MD, FACP, Scot Remick, MD, FACP, Michael Craig, MD, Sayed Mehdi Hamadani, MD
Journal: Blood
Blood (2010) 116 (21): 1272.
https://doi.org/10.1182/blood.V116.21.1272.1272
Published: 2010
Journal Articles

Disruption of the Crosstalk CXCL12/CXCR4 Chemotactic Pathway To Enhance Melphalan-Induced Apoptosis in Multiple Myeloma Cell Lines.

Ayman A. Saad, MD, James Fortney, BS, Lin Wang, Ph D, Heather O’Leary, BS, Laura Gibson, PHD, Solveig Ericson, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 3445.
https://doi.org/10.1182/blood.V108.11.3445.3445
Published: 2006